Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
NCT05948943· Phase 2/3· Novartis Pharmaceuticals· Source
Contact: Melissa Casey
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error